dacarbazine,pegfilgrastim,doxorubicin,nivolumab,brentuximab vedotin,vinblastine,filgrastim
amgen,bms,seagen
['nivo']
 once we do establish this as standard of care, the next step would ideally be how much nivo. if a ptnt is pet2 negative, can we stop nivo? or can we use low dose nivo? these would make these drugs more accessible in lmics
Clinical Hematologist at PGIMER, Chandigarh. Life-long Arsenal fan. Passionate about Myeloma and Lymphoma